Figure 4.

Kaplan-Meier estimator curves for the correlation between overall survival or disease-free survival and DHX32 protein expression. (A) Overall survival curves of patients with breast cancer. P=0.002 for high vs. low DHX23 expression, as calculated by the log-rank test. (B) Disease-free survival curves of patients with breast cancer. P=0.007 for high vs. low DHX23 expression, as calculated by the log-rank test. High or low DHX32 expression was determined by immunohistochemistry analysis. DHX32, DEAH-box helicase 32.